Work

Tildrakizumab drug survival: can we really attribute the benefit to male sex?

Year: 2026

Type: article

Source: Clinical and Experimental Dermatology

DOI: 10.1093/ced/llag050

Authors: Yumei Li, Yonghua Su

Institutions: Shanghai University of Traditional Chinese Medicine, Yueyang Hospital

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7126186129

FWCI:

Cites: 1

Cited by:

Related to: